The Lancet in conversation with

The Lancet Group

Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.

All episodes

Best episodes

Top 10 The Lancet in conversation with Episodes

Goodpods has curated a list of the 10 best The Lancet in conversation with episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Lancet in conversation with for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Lancet in conversation with episode by adding your comments to the episode page.

Shawn St Peter on appendicectomy versus antibiotics for acute uncomplicated appendicitis in children

The Lancet in conversation with

01/27/25 • 16 min

This week, we discuss treatment approaches for uncomplicated appendicitis in children following the publication of a trial in our January 18th issue. Lead author Shawn St Peter, general paediatric surgeon and surgeon-in-chief at Children’s Mercy Hospital, Kansas City, spoke with Callam Davidson about the motivation behind the study, key findings, and what the results mean for clinical practice.
Read the full article:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02420-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Previewing ASCO 2025

The Lancet in conversation with

05/30/25 • 4 min

Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, joins Gavin Cleaver to discuss what's being published at this year's American Society of Clinical Oncology (ASCO) meeting, what she's excited to see at the conference, and why ASCO is so important to the field.

Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours

The Lancet in conversation with

05/31/25 • 14 min

Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer.

Read the full article:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00860-8/fulltext?dgcid=buzzsprout_icw_podcast_May_25_lancet

ASCO 2025 Debrief

The Lancet in conversation with

06/11/25 • 14 min

Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, and Katherine Gourd, Acting Deputy Editor at The Lancet Oncology, join Leon Terner to share some of their experiences, impressions and highlights from this year's American Society of Clinical Oncology (ASCO) conference.

If you haven't already, be sure to listen to Vania's pre-ASCO predictions podcast here: https://www.buzzsprout.com/882697/episodes/17233167

Articles discussed in this podcast episode include:

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00287-6/fulltext?dgcid=buzzsprout_icw_podcast_asco2025_lancet_tlw

Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00860-8/fulltext?dgcid=buzzsprout_icw_podcast_asco2025_lancet_tlw

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01040-2/fulltext?dgcid=buzzsprout_icw_podcast_asco2025_lancet_tlw

#asco2025

The Lancet: September 18, 2009

The Lancet in conversation with

09/18/09 • 24 min

Discussion of sexual and reproductive health, and an interview with NIH Director Francis Collins.

Richard Horton, Sarah Dalglish, and Grace Gatera

The Lancet in conversation with

02/19/20 • 16 min

Richard Horton, Sarah Dalglish, and Grace Gatera talk about the future for children alive today, alongside findings from the new Commission.

The Lancet: September 21, 2012

The Lancet in conversation with

09/21/12 • 9 min

Sharmila Devi discusses racial inequities in health in the United States, and details of a surgery themed issue.

The Lancet: August 03, 2012

The Lancet in conversation with

08/03/12 • 3 min

The Lancet Commission on Global Health Technologies.

The Lancet: October 07, 2011

The Lancet in conversation with

10/07/11 • 8 min

Sharmila Devi discusses the situation in Bahrain, where health professionals have been arrested for aiding protesters earlier this year.

Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial)

The Lancet in conversation with

10/31/24 • 48 min

ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and service user representative Fehmida Motala.
Read the full article:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01612-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet

Show more best episodes

FAQ

How many episodes does The Lancet in conversation with have?

The Lancet in conversation with currently has 662 episodes available.

What topics does The Lancet in conversation with cover?

The podcast is about Covid, Life Sciences, Health Care, Health & Fitness, Research, Medicine, Podcasts and Science.

What is the most popular episode on The Lancet in conversation with?

The episode title 'Nick James on the STAMPEDE trial' is the most popular.

What is the average episode length on The Lancet in conversation with?

The average episode length on The Lancet in conversation with is 13 minutes.

How often are episodes of The Lancet in conversation with released?

Episodes of The Lancet in conversation with are typically released every 7 days.

When was the first episode of The Lancet in conversation with?

The first episode of The Lancet in conversation with was released on Jul 22, 2006.

Show more FAQ

The Lancet in conversation with

The Lancet Group

Top 10 The Lancet in conversation with Episodes

FAQ

How many episodes does The Lancet in conversation with have?

What topics does The Lancet in conversation with cover?

What is the most popular episode on The Lancet in conversation with?

What is the average episode length on The Lancet in conversation with?

How often are episodes of The Lancet in conversation with released?

When was the first episode of The Lancet in conversation with?

Comments